Mark D. Eisner - Publications, H-index & Citations

Mark D. Eisner

newcastle university - uk

72H指数

278论文数

2.0W被引数

收录论文 83

发表时间

Comment on 'A proposal for a new pathogenesis-guided classification for inherited epidermal differentiation disorders'评述‘一种基于发病机制指导的新分类法用于遗传性表皮分化障碍’

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2025-05-01

PREAI

Eisner, Mark; Sharkey, Thomas; Common, John; Rajan, Neil

YAP1-NUTM1 fusions are infrequent in porocarcinomas arising in a cohort including immunocompromised patients YAP1-NUTM1融合在包括免疫抑制患者在内的队列中发生的汗腺癌中不常见。

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

IF8

2025-04-02

PREAI

Eisner, Mark; Winn, Remus; Oliphant, Tom; Xavier, Miguel Joao; Husain, Akhtar; Harwood, Catherine A.; Rajan, Neil

Restoring Atrial T-Tubules Augments Systolic Ca Upon Recovery From Heart Failure

CIRCULATION RESEARCH

IF16.2

2024-09-13

OAAI

Caldwell, Jessica L.; Clarke, Jessica D.; Smith, Charlotte E. R.; Pinali, Christian; Quinn, Callum J.; Pearman, Charles M.; Adomaviciene, Aiste; Radcliffe, Emma J.; Watkins, Amy; Horn, Margaux A.; Bode, Elizabeth F.; Madders, George W. P.; Eisner, Mark; Eisner, David A.; Trafford, Andrew W.; Dibb, Katharine M.

A case of missing fingerprints

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2024-06-24

PREAI

Eisner, Mark; Rajan, Neil

Shingles in two children with no history of chicken pox

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2024-01-03

PREAI

Eisner, Mark; Darne, Sharmela

Roxadustat for chemotherapy-induced anemia in patients with non-myeloid malignancies: A randomized, open- label, active-controlled, phase III study

ANNALS OF ONCOLOGY

IF65.4

2023-10-01

OAAI

Lu, S.; Wu, J.; Jiang, J.; Guo, Q.; Yu, Y.; Liu, Y.; Zhang, H.; Qian, L.; Dai, X.; Xie, Y.; Fu, T.; Lee, T.; Lu, Y.; Ma, R.; Eisner, M.

DP14 Going against the grain: eosinophilic dermatosis presenting as erythema gyratum repens

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2023-06-26

OAAI

Ting, Jason Siong Kai; Eisner, Mark; Venkatesan, Sowmya; Fatah, Saman

Pamrevlumab, a Fully Human Monoclonal Antibody Targeting Connective Tissue Growth Factor, for Non-Ambulatory Patients with Duchenne Muscular Dystrophy

JOURNAL OF NEUROMUSCULAR DISEASES

IF3.4

2023-05-24

OAAI

Connolly, Anne M.; Zaidman, Craig M.; Brandsema, John F.; Phan, Han C.; Tian, Cuixia; Zhang, Xueping; Li, Jack; Eisner, Mark D.; Carrier, Ewa

A novel event-free survival endpoint in locally advanced pancreatic cancer 局部晚期胰腺癌新的无事件生存终点

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

IF4.2

2021-11-29

OAAI

Hammel, Pascal; Carrier, Ewa; Carney, Mairead; Eisner, Mark; Fleming, Thomas

Model-based approach for methoxy polyethylene glycol-epoetin beta drug development in paediatric patients with anaemia of chronic kidney disease

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2020-01-21

OAAI

Chanu, Pascal; Schaefer, Franz; Warady, Bradley A.; Schmitt, Claus Peter; Reigner, Bruno; Schnetzler, Gabriel; Reigner, Sylvie Meyer; Eisner, Mark; Weichert, Arlette; Frey, Nicolas

Code-based Diagnostic Algorithms for Idiopathic Pulmonary Fibrosis Case Validation and Improvement

ANNALS OF THE AMERICAN THORACIC SOCIETY

IF5.4

2017-06-01

OAAI

Ley, Brett; Urbania, Thomas; Husson, Gail; Vittinghoff, Eric; Brush, David R.; Eisner, Mark D.; Iribarren, Carlos; Collard, Harold R.

Cardiovascular and cerebrovascular events among patients receiving omalizumab: Results from EXCELS, a prospective cohort study in moderate to severe asthma

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

IF11.2

2017-05-01

OAAI

Iribarren, Carlos; Rahmaoui, Abdelkader; Long, Aidan A.; Szefler, Stanley J.; Bradley, Mary S.; Carrigan, Gillis; Eisner, Mark D.; Chen, Hubert; Omachi, Theodore A.; Farkouh, Michael E.; Rothman, Kenneth J.

Cardiovascular and cerebrovascular events among patients receiving omalizumab: Pooled analysis of patient-level data from 25 randomized, double-blind, placebo-controlled clinical trials

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

IF11.2

2017-05-01

OAAI

Iribarren, Carlos; Rothman, Kenneth J.; Bradley, Mary S.; Carrigan, Gillis; Eisner, Mark D.; Chen, Hubert

LATE-BREAKING ABSTRACT: LAVOLTA I and II: Results of 2 phase III studies to assess the efficacy and safety of lebrikizumab in patients with uncontrolled asthma

EUROPEAN RESPIRATORY JOURNAL

IF21

2016-11-08

PREAI

Hanania, Nicola; Korenblat, Phillip; Chapman, Kenneth R.; Bateman, Eric D.; Kopecky, Petr; Paggiaro, Pier L.; Yokoyama, Akihito; Olsson, Julie; Gray, Sarah; Holweg, Cecile T. J.; Eisner, Mark; Asare, Charles; Matthews, John G.

Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials

LANCET RESPIRATORY MEDICINE

IF32.8

2016-10-01

373

PREAI

Hanania, Nicola A.; Korenblat, Phillip; Chapman, Kenneth R.; Bateman, Eric D.; Kopecky, Petr; Paggiaro, Pierluigi; Yokoyama, Akihito; Olsson, Julie; Gray, Sarah; Holweg, Cecile T. J.; Eisner, Mark; Asare, Charles; Fischer, Saloumeh K.; Peng, Kun; Putnam, Wendy S.; Matthews, John G.

Understanding the impact of second-hand smoke exposure on clinical outcomes in participants with COPD in the SPIROMICS cohort

THORAX

IF7.7

2016-03-09

OAAI

Putcha, Nirupama; Barr, R. Graham; Han, Meilan K.; Woodruff, Prescott G.; Bleecker, Eugene R.; Kanner, Richard E.; Martinez, Fernando J.; Smith, Benjamin M.; Tashkin, Donald P.; Bowler, Russell P.; Eisner, Mark D.; Rennard, Stephen I.; Wise, Robert A.; Hansel, Nadia N.

An audit of best evidence topic reviews in the International Journal of Surgery

INTERNATIONAL JOURNAL OF SURGERY

IF10.1

2015-05-01

OAAI

Mabvuure, Nigel Tapiwa; Klimach, Stefan; Eisner, Mark; Rodrigues, Jeremy Neil

Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

IF11.2

2014-09-01

175

OAAI

Long, Aidan; Rahmaoui, Abdelkader; Rothman, Kenneth J.; Guinan, Eva; Eisner, Mark; Bradley, Mary S.; Iribarren, Carlos; Chen, Hubert; Carrigan, Gillis; Rosen, Karin; Szefler, Stanley J.

Risk Adjustment for Health Care Financing in Chronic Disease What Are We Missing By Failing to Account for Disease Severity?慢性病卫生保健筹资的风险调整未能考虑到疾病的严重程度，我们遗漏了什么？

MEDICAL CARE

IF2.8

2013-08-01

OAAI

Omachi, Theodore A.; Gregorich, Steven E.; Eisner, Mark D.; Penaloza, Renee A.; Tolstykh, Irina V.; Yelin, Edward H.; Iribarren, Carlos; Dudley, R. Adams; Blanc, Paul D.

Population-Based Efficacy Modeling of Omalizumab in Patients with Severe Allergic Asthma Inadequately Controlled with Standard Therapy

AAPS JOURNAL

IF3.7

2013-02-15

OAAI

Zhu, Rui; Zheng, Yanan; Putnam, Wendy S.; Visich, Jennifer; Eisner, Mark D.; Matthews, John G.; Rosen, Karin E.; D'Argenio, David Z.

研究方向